ArticleBritish journal of haematology2015

Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD immunomodulatory drug pomalidomide.

Deepika S Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.